-
Gore to debut GORE™ ImproJect™ plunger for sensitive biologics in pre-filled syringes
europeanpharmaceuticalreview
May 05, 2019
Gore to debut GORE™ ImproJect™ plunger for sensitive biologics in pre-filled syringes.
-
WuXi Biologics, I-Mab Biopharma Ink Long-term Strategic Pact
contractpharma
April 17, 2019
WuXi to provide CMC development and commercial manufacturing.
-
China Biologic announces updates on unsolicited acquisition proposals
biospectrumasia
August 28, 2018
After careful review of the Consortium's proposal, the Board has unanimously determined that it is not in the best interests of the Company and its shareholders
-
Safety Concerns Force Loss of Breakthrough Therapy Designation for Synthetic Biologic’s C. Diff Drug
biospace
April 24, 2018
This morning, the share price of synthetic biopharmaceutical companies headquartered in Rockville, Maryland, fell more than 14% and last year's drug administration
-
US green lights new biologic for psoriasis
pharmatimes
March 23, 2018
The US Food and Drug Administration has approved Sun Pharma’s Ilumya as a new treatment option for adults with moderate-to-severe plaque psoriasis.
-
China Biologic Reports Unaudited Financial Results for the Third Quarter of 2017
prnasia
November 02, 2017
China Biologic Products Holdings, Inc. (NASDAQ: CBPO, "China Biologic" or the "Company"), a leading fully integrated plasma-based biopharmaceutical company in China, today announced its unaudited financial results for the third quarter of 2017.
-
EU approves LEO Pharma’s psoriasis biologic
pharmatimes
July 21, 2017
A new treatment option has been approved in the European Union for patients with psoriasis,,